Calla Lily Clinical Care Ltd
1 clinical trials · Sponsor
◉ Watch Calla Lily Clinical Care Ltd
| Record | Firm | Date |
|---|---|---|
| First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency (NCT07136922) | Calla Lily Clinical Care Ltd | 2026-04-20 |
Track Calla Lily Clinical Care Ltd automatically
Every clearance here is in the API, with alerts when new ones post.